The dates and venue for the upcoming Hematology event will be announced shortly.
For further details, Please contact us at secretary@magnusmeetings.com or call + 1 (702) 988 2320.
Platelets are little blood cells that assist your body stop bleeding by forming clots. When a blood artery in your body is injured, it sends signals to your platelets. Platelets rush to the damaged area and form a plug (clot) to stop the bleeding. Adhesion is the process of a substance spreading across the surface of a damaged blood vessel to halt bleeding. This is because platelets develop sticky tentacles that help them stick (adhere) to one another when they reach the injury site. Chemical signals are also sent out to recruit additional platelets. Aggregation is the process through which more platelets build up on the clot.
Coagulation, also known as clotting, is the transformation of blood from a liquid to a gel, resulting in the formation of a blood clot. It could lead to haemostasis, or the halt of blood loss from a damaged vessel, and then repair. Coagulation is caused by platelet activation, adhesion, and aggregation, as well as fibrin deposition and maturation. After a damage to the endothelium lining a blood artery, coagulation begins nearly immediately. When blood is exposed to the subendothelial space, two processes occur: platelet modifications and the exposure of subendothelial tissue factor to plasma factor VII, which results in the creation of cross-linked fibrin.
Coagulation is the process of forming a blood clot, which is necessary for haemostasis. The body's physiological response to injured blood arteries is haemostasis, which lowers, minimises, and eventually stops bleeding. The creation of a blood clot is characterised by a series of processes known as the coagulation process. Clotting factors are proteins that start processes that trigger other clotting factors. This happens through two routes that come together downstream to establish a single pathway that facilitates haemostasis.
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan Lluis Vives Corrons, Institute for Leukaemia Research Josep Carreras, Spain
Title : Histologic transformation of mantle zone lymphoma to diffuse large B-Cell lymphoma: A case report of disease relapse after Covid-19 infection
Lilija Bancevica, Riga Stradins University, Latvia
Title : Improving outcomes of curable lymphoma in resource constrained regions
Reena Nair, TATA Medical Centre, India
Title : Covid-19 and erythrocyte groups
Marina Nagervadze, Batumi Shota Rustaveli State University, Georgia
Title : Achieving 100% blood traceability compliance: A United Kingdom district hospital experience
Francis Ajeneye, Princess Alexandra Hospital NHS Trust, United Kingdom
Title : Role of erythrocytapheresis in sickle cell anemia crisis management: A tertiary care centre experience from Chhattisgarh state of central India
Neelesh Jain, Transfusion Medicine at Balco Medical Centre, India